Huiling Zhou

536 total citations · 1 hit paper
22 papers, 375 citations indexed

About

Huiling Zhou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Huiling Zhou has authored 22 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Huiling Zhou's work include Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (4 papers) and Cancer-related Molecular Pathways (3 papers). Huiling Zhou is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (4 papers) and Cancer-related Molecular Pathways (3 papers). Huiling Zhou collaborates with scholars based in China and United States. Huiling Zhou's co-authors include Haidan Liu, Lijun Liu, Yifeng Yang, Jian Wang, Xinfang Yu, Xuyang Hou, Xinmin Zhou, Xiaolong Ma, Wei Li and Runzhou Ni and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and International Journal of Biological Macromolecules.

In The Last Decade

Huiling Zhou

21 papers receiving 373 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer

2024 58 citations Shunan Zhang, Huiling Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huiling Zhou China	12	292	99	86	53	43	22	375
Faying Xu China	4	289 1.0×	115 1.2×	105 1.2×	41 0.8×	36 0.8×	6	391
Bi‐Jun Huang China	10	248 0.8×	126 1.3×	106 1.2×	75 1.4×	51 1.2×	36	382
Jia-Rong Huang China	15	327 1.1×	138 1.4×	140 1.6×	71 1.3×	51 1.2×	26	498
Xuyang Hou China	12	304 1.0×	140 1.4×	69 0.8×	46 0.9×	40 0.9×	22	410
Hamidreza Saebfar Iran	9	265 0.9×	154 1.6×	106 1.2×	61 1.2×	36 0.8×	10	421
Bettina Miller United States	10	230 0.8×	115 1.2×	172 2.0×	34 0.6×	72 1.7×	14	404
Violeta Jonušienė Lithuania	10	214 0.7×	93 0.9×	85 1.0×	61 1.2×	45 1.0×	20	356
Iryna Kolosenko Sweden	11	237 0.8×	91 0.9×	116 1.3×	25 0.5×	68 1.6×	19	383
Kanqiu Jiang China	11	242 0.8×	115 1.2×	128 1.5×	51 1.0×	68 1.6×	15	406
Yang-ling Li China	11	229 0.8×	102 1.0×	82 1.0×	77 1.5×	27 0.6×	22	350

Countries citing papers authored by Huiling Zhou

Since Specialization

Citations

This map shows the geographic impact of Huiling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Zhou more than expected).

Fields of papers citing papers by Huiling Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Zhou. The network helps show where Huiling Zhou may publish in the future.

Co-authorship network of co-authors of Huiling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huiling Zhou. A scholar is included among the top collaborators of Huiling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiling Zhou. Huiling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Huiling, Bo Hou, Lujia Huang, et al.. (2025). De Novo Design of Structure‐Tunable Multivalent Targeting Chimeras for Tumor‐Targeted PD‐L1 Degradation and Potentiated Cancer Immunotherapy. Angewandte Chemie International Edition. 64(27). e202504233–e202504233. 1 indexed citations

Wang, Cong, Xuyang Hou, Huiling Zhou, et al.. (2025). USP10-stabilized IGF2BP3 promotes tumor growth via m6A-modified SKP2 mRNA in non-small-cell lung cancer. International Journal of Biological Macromolecules. 329(Pt 1). 147753–147753.

Zhou, Huiling, et al.. (2024). Neu5Gc regulates decidual macrophages leading to abnormal embryo implantation. Genes and Immunity. 25(2). 149–157. 1 indexed citations

Zhou, Huiling, Li Zhou, Xuyang Hou, et al.. (2023). Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells. Communications Biology. 6(1). 805–805. 20 indexed citations

Hou, Xuyang, Qing Guan, Huiling Zhou, et al.. (2023). RNA modification in cardiovascular disease: implications for therapeutic interventions. Signal Transduction and Targeted Therapy. 8(1). 412–412. 49 indexed citations

Zhou, Huiling, et al.. (2023). Effect of COVID-19 inactivated vaccine on peripheral blood anti-β2-GPI antibody and outcomes in vitro fertilization-embryo transplantation. International Immunopharmacology. 122. 110596–110596. 2 indexed citations

Zhou, Huiling, et al.. (2022). Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. International Journal of Biological Sciences. 18(13). 4869–4883. 7 indexed citations

Zhou, Huiling, et al.. (2022). Case Report: Mycobacterium senegalense Infection After Cholecystectomy. Frontiers in Public Health. 10. 899846–899846. 1 indexed citations

Zhou, Huiling, et al.. (2022). MKI67 as a potential diagnostic biomarker in pulmonary hypertension. Frontiers in Pediatrics. 10. 1016889–1016889. 5 indexed citations

10.

Gong, Ke, Huiling Zhou, Haidan Liu, et al.. (2021). Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Technology in Cancer Research & Treatment. 20. 2203802090–2203802090. 21 indexed citations

11.

Zhang, Zhigang, et al.. (2020). Exercise training suppresses Mst1 activation and attenuates myocardial dysfunction in mice with type 1 diabetes. Canadian Journal of Physiology and Pharmacology. 98(11). 777–784. 7 indexed citations

12.

Zhou, Huiling, Lijun Liu, Xiaolong Ma, et al.. (2020). RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage. Molecular and Cellular Biochemistry. 476(2). 1233–1243. 27 indexed citations

13.

Yu, Hong, Xiaoqin Jiang, Jiang Lin, et al.. (2020). Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma. Medical Science Monitor. 26. e920665–e920665. 11 indexed citations

14.

Li, Bin, Zhirui Guo, Liang Quan, et al.. (2019). <p>lncRNA DGCR5 Up-Regulates TGF-β1, Increases Cancer Cell Stemness and Predicts Survival of Prostate Cancer Patients</p>. Cancer Management and Research. Volume 11. 10657–10663. 12 indexed citations

15.

Li, Wei, Xinfang Yu, Xiaolong Ma, et al.. (2018). Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway. Cellular Signalling. 50. 131–141. 43 indexed citations

16.

Zhou, Huiling, Jingjing Bao, Xiaowei Zhu, et al.. (2018). Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma. BioMed Research International. 2018. 1–9. 10 indexed citations

17.

Liu, Jinxia, Wenkai Ni, Lishuai Qu, et al.. (2016). Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 61(9). 2554–2567. 14 indexed citations

18.

Li, Chunsun, Chunhua Wan, Qingqing Liu, et al.. (2016). Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 62(1). 133–142. 7 indexed citations

19.

Hu, Baoying, Yan Xia, Fang Liu, et al.. (2015). Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression. Pathology & Oncology Research. 22(3). 555–565. 13 indexed citations

20.

Xia, Yan, Huiling Zhou, Tingting Zhang, et al.. (2015). Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion. Tumor Biology. 36(12). 9611–9619. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact